Uncategorized
VIDEO: Shire moves forward with lifitegrast in wake of OPUS 3 results
LAS VEGAS — At the Ophthalmology Innovation Summit, Robert Dempsey, vice president and head of ophthalmology at Shire, discusses the company’s plans moving forward for lifitegrast in dry eye treatment.